Check out your Company Bowl for anonymous work chats.
As we kick off the new year, we are excited to announce that Stephen Gillett officially begins his tenure as CEO of Verily today. Read about his vision to take Verily to new heights in our next chapter!
Stephen Gillett begins tenure as Verily CEO | Verily Life Sciences
In the paper, “Diversity, Equity, and Inclusion in Clinical Research: a Path Towards Precision Health for Everyone” in American Society for Clinical Pharmacology & Therapeutics, Verily leaders share strategies to build more inclusion into clinical trials, make health more equitable, and advance #PrecisionHealth. Take a look:
Achieving Diverse Representation in Clinical Trials
90% of severe vision loss caused by diabetes is preventable with early detection and treatment strategies. Discover how Verily Retinal Service aims to expand access to quality eye screenings with our integrated platform, bringing solutions where they’re needed most to drive meaningful change for people with diabetes.
Retinal Camera Service | Verily Life Sciences
#HLTH2022 may be over, but our team is still thinking about the conversations surrounding the future of health. One thing was clear: the first step towards building meaningful solutions is designing for the needs of the individual with a data-driven approach. Read on for more show takeaways and insights from our leaders:.
Verily @HLTH2022 | Verily Life Sciences
A few of us at Verily woke up a little extra early this morning to give back to the Bay Area at a Food Distribution event with Second Harvest of Silicon Valley. We had a great time and are looking forward to doing this again! Thank you Sudha Rao MD FCAP FASCP, Poonam Rakhya, Annie Chau, Sunny Desai, Bethlyn "Buffy" Craner Parada, MPH, CPH for making this great! #giveback #volunteering #grateful
A few of us at Verily woke up a little extra early this morning to give back to the Bay Area at a Food Distribution event with Second Harvest of Silicon Valley. We had a great time and are looking forward to doing this again! Thank you Sudha Rao MD FCAP FASCP, Poonam Rakhya, Annie Chau, Sunny Desai, Bethlyn "Buffy" Craner Parada, MPH, CPH for making this great! #giveback #volunteering #grateful
On Day 3 at #HLTH2022, Vivian S. Lee, MD, PhD, MBA, President of Verily Health Platforms, joined Greg Meyers of Bristol Myers Squibb, Javier Rodriguez of DaVita Kidney Care, Paul A. King of Stanford Children's Health, and A.G. Breitenstein of Define Ventures to discuss "What's Plaguing Our Health." A big topic of conversation was mental and behavioral health. Today's leaders need to build digital health tools with the intention to drive more access and engagement for all communities. "The data supports this—if you look at mental and behavioral health, a co-diagnosis of depression increases the overall cost of care by 30-50%. If you can talk about things holistically, access to mental and behavioral health services is better for the patient, and it's also better for the economy." - Vivian S. Lee, MD, PhD, MBA
On Day 3 at #HLTH2022, Vivian S. Lee, MD, PhD, MBA, President of Verily Health Platforms, joined Greg Meyers of Bristol Myers Squibb, Javier Rodriguez of DaVita Kidney Care, Paul A. King of Stanford Children's Health, and A.G. Breitenstein of Define Ventures to discuss "What's Plaguing Our Health." A big topic of conversation was mental and behavioral health. Today's leaders need to build digital health tools with the intention to drive more access and engagement for all communities. "The data supports this—if you look at mental and behavioral health, a co-diagnosis of depression increases the overall cost of care by 30-50%. If you can talk about things holistically, access to mental and behavioral health services is better for the patient, and it's also better for the economy." - Vivian S. Lee, MD, PhD, MBA
In today’s #HLTH2022 panel, "The Broken Trust Between Public and Health,” Amy Abernethy, President of Verily Clinical Platforms, discussed building trust in digital health solutions by "leveraging the best of user experience and design to not only build understanding and trust, but also make it so that I have the information I need for the moment I need it." It was an insightful chat with Anjalee Khemlani, Leana Wen M.D. M.Sc., and Zeke Emanuel. #DigitalHealth #VerilyAtHLTH
Verily on LinkedIn: #hlth2022 #digitalhealth #verilyathlth
New data show Onduo, a Verily company significantly improves blood glucose and cholesterol levels among employees living with type 2 diabetes. The findings from a recent study were presented at American Heart Association's (AHA) Scientific Sessions 2022. “Data and technology coupled with personalized, precision care can identify the moments of greatest impact and help people adopt healthier behaviors.” -Erich S. Huang, MD, PhD, Chief Science and Innovation Officer at Onduo, Verily’s virtual care solution for people living with chronic conditions. Read more details about the study results.
New Data Show Onduo by Verily Significantly Improves Glycemic Levels Among Employees Living with Type 2 Diabetes at American Heart Association's Scientific Sessions 2022 | Verily Life Sciences
We are proud to announce that Stephen Gillett, our President & COO, is recognized as a Top 25 Healthcare COO of 2022 by The Healthcare Technology Report. He has leveraged his entrepreneurship and technological expertise to drive new health innovations at Verily. We look forward to seeing him in his new role as CEO in January 2023. Congratulations to Stephen and everyone on the Top 25 Healthcare COO list. #HealthTech #HealthcareInnovation
The Top 25 Healthcare Technology COOs of 2022
How do we become smarter in our approach to helping people manage chronic conditions, like type 2 diabetes and hypertension, well before their health is at risk? It starts with data. To shift the care paradigm from one-size-fits-all and provide personalized interventions, we need to understand the many factors that influence a person’s health. Read how our Onduo solution aims to do just that.
A data-driven, personalized approach to chronic care | Verily Life Sciences